TimeMagazine

Blockbuster weight loss and diabetes drugs may lower patients’ risk of developing some common types of cancer that are closely linked to obesity, new evidence suggests. Patients with Type 2 diabetes who were prescribed drugs known as glucagon-like peptide-1, or GLP-1, developed fewer obesity-related cancers than patients who were treated with insulin, according to a … Read more

A staggering 129 million Americans have at least one major chronic disease—and 90% of our $4.1 trillion in annual health care spending goes toward treating these physical and mental-health conditions. That financial and personal toll is only projected to grow. We know this is unsustainable. But there are solutions, because health outcomes are shaped by … Read more

This Independence Day, competitors at Nathan’s Famous hot dog eating contest may gulp down as many as 76 wieners in about the time it takes to read this article. Like ultramarathoners hoofing 50 miles or football players shaking off big hits, “speed-eating” entails natural resilience, dedicated training, and serious risks to health. Some may see … Read more

Federal health officials are investigating a possible death and dozens of illnesses tied to recalled “microdosing” candies laced with a chemical found in mushrooms and sold online and in vape shops nationwide. At least 48 people in 24 states said they got sick after eating Diamond Shruumz-brand products, including chocolate bars, cones and gummies, the U.S. Food … Read more

On July 2, the U.S. Food and Drug Administration (FDA) approved a new drug for treating Alzheimer’s disease. Donanemab, or Kisunla, is the third drug approved to target one of the causes of Alzheimer’s: the buildup of amyloid protein in the brain. Based on the data provided by the drug’s manufacturer, Eli Lilly, for the … Read more

(WASHINGTON) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s. It’s only the second … Read more

Imagine what else you could do with the hours you spend unconscious each night. Oh, the things you could accomplish! But if you’re trying to claw back more of your personal time, sacrificing sleep is not where to start. The American Academy of Sleep Medicine and the Sleep Research Society both recommend a minimum of … Read more

The Fourth of July holiday can often be a great opportunity to visit the seaside for a sandy getaway. But local governments across the U.S. have issued warnings and closures to stay away from certain shores due to alarmingly high bacteria levels. As of Monday afternoon, at least 29 beaches in Massachusetts have been reported … Read more

The U.S. Centers for Disease Control and Prevention (CDC) has recommended updated vaccines for the fall to protect against common respiratory diseases. Among the changes: people age 75 and older should get vaccinated against RSV, the COVID-19 vaccine will target a new strain of the virus, and the updated flu shot will include only three … Read more

After Jackie Trapp was diagnosed with multiple myeloma, an incurable blood cancer, in 2015, she thought her biggest health shock was behind her. Then came the bills for Revlimid, a powerful cancer drug that her doctor said was her best hope for controlling the disease. The first month’s supply cost $11,148; the second, $12,040—and her … Read more